Skip to main content
The Journal of Neuroscience logoLink to The Journal of Neuroscience
. 2003 Jul 30;23(17):6728–6739. doi: 10.1523/JNEUROSCI.23-17-06728.2003

Differential Properties of Astrocyte Calcium Waves Mediated by P2Y1 and P2Y2 Receptors

Conor J Gallagher 1,3, Michael W Salter 1,2,3
PMCID: PMC6740738  PMID: 12890765

Abstract

Intercellular spread of Ca2+ waves is the primary manifestation of cell-to-cell communication among astrocytes. Ca2+ waves propagate via the release of a diffusible extracellular messenger that has been identified as ATP. In dorsal spinal astrocytes, Ca2+ waves are mediated by activation of two functionally distinct subtypes of metabotropic purinoceptor: the P2Y1 receptor and a receptor previously classified as P2U. Here, we show that the P2U receptor is molecularly and pharmacologically identical to the cloned P2Y2 receptor. Both P2Y1 and P2Y2 receptors are necessary for full Ca2+ wave propagation in spinal astrocytes. Conversely, heterologous expression of either P2Y1 or P2Y2 receptors is sufficient for Ca2+ waves, and expressing these receptor subtypes together recapitulates the characteristics of Ca2+ waves in spinal astrocytes. Thus, P2Y1 and P2Y2 receptors are both necessary and sufficient for propagation of Ca2+ waves. Furthermore, we demonstrate that there are dramatic differences in the characteristics of Ca2+ waves propagating through each receptor subtype: Ca2+ waves propagating via P2Y2 receptors travel faster and further than those propagating via P2Y1 receptors. We find that the nucleotidase apyrase selectively blocks Ca2+ wave propagation through P2Y2 receptors but accelerates Ca2+ waves propagating through P2Y1 receptors. Taking our results together with those from the literature, we suggest that mediation of Ca2+ waves by ATP leading to activation of two subtypes of receptor, P2Y1 and P2Y2, may be a general principle for gliotransmission in the CNS. Thus, processes that alter expression or function of these receptors may control the rate and extent of astrocyte Ca2+ waves.

Keywords: Ca2+ waves, astrocytes, purinoceptors, spinal cord, apyrase, imaging

Introduction

In astrocyte networks, elevations in intracellular [Ca2+] ([Ca2+]i) propagate from one cell to another as spreading Ca2+ waves (Cornell-Bell et al., 1990; Charles et al., 1991). Ca2+ signaling in astrocytes is a principal means for responding to environmental stimuli, and increases in [Ca2+]i lead to growth, differentiation, and release of neuroactive mediators (Vernadakis, 1996). Spread of Ca2+ waves may underlie an astrocyte-based long-range signaling system in the CNS. The passage of Ca2+ waves through astrocyte networks has been shown to influence the efficacy of neurotransmission at adjacent synapses (Nedergaard, 1994; Newman and Zahs, 1998), and neuronal activity has been shown to evoke Ca2+ elevations in astrocytes (Araque et al., 2002). Thus, Ca2+ waves may be a mechanism for encoding and transmitting information that complements and interacts with electrical signaling of neurons (Bezzi and Volterra, 2001).

Astrocyte Ca2+ waves have been shown to propagate by means of a diffusible extracellular messenger (Hassinger et al., 1996; Guthrie et al., 1999). A growing body of evidence has implicated ATP as the principal messenger mediating Ca2+ wave propagation: ATP is released from astrocytes during Ca2+ wave propagation (Cotrina et al., 1998a; Guthrie et al., 1999); applying ATP evokes Ca2+ responses in astrocytes (Neary et al., 1988; Salter and Hicks, 1994); and Ca2+ waves are blocked by antagonists of ATP-activated metabotropic receptors [P2Y receptors (P2YRs)] (Guan et al., 1997; Cotrina et al., 1998a; Guthrie et al., 1999; Fam et al., 2000). This evidence leads to a model for Ca2+ wave propagation whereby ATP is released from astrocytes and activates P2YRs.

P2Y receptors are the subclass of the G-protein-coupled receptor superfamily that are activated by extracellular nucleotides, including ATP. The P2YR family comprises seven confirmed gene products: P2Y1, 2, 4, 6, and 11-13. Astrocytes express two functional subtypes of P2YR (Ho et al., 1995) both of which are necessary for full propagation of Ca2+ waves (Fam et al., 2000). One of these receptors has been identified pharmacologically and molecularly as the cloned P2Y1R (Fam et al., 2000). The P2Y1R is activated by ATP and ADP but not by UTP or UDP. The other subtype of P2YR expressed by astrocytes has been functionally classified as P2U because it is activated equipotently by UTP and ATP but is unaffected by ADP or UDP (Ho et al., 1995). However, the pharmacological profile of the UTP-mediated responses of astrocytes does not match that previously reported for any cloned P2YR. Thus, the molecular identity of the P2U receptor, which is critical for astrocyte Ca2+ wave propagation, remains unknown.

In the present study, we clarify the pharmacological properties of Ca2+ responses mediated by UTP-sensitive P2YRs from the rat and show molecularly and pharmacologically that the receptor mediating the UTP responses of astrocytes is P2Y2. Furthermore, we have discovered that Ca2+ waves mediated by P2Y2Rs propagate dramatically faster than do those mediated via P2Y1Rs. We have determined that, on activation by ATP, P2Y2Rs generate a rise in [Ca2+]i more rapidly than do P2Y1Rs, and this underlies the differential rates of Ca2+ wave propagation.

Materials and Methods

Cell culture. Primary dissociated cultures of dorsal spinal cord were prepared from embryonic day 17-18 rats and maintained as described in detail elsewhere (Salter and Hicks, 1994). Briefly, timed pregnant Wistar rats were anesthetized, and embryos were removed surgically. The spinal cord was extracted from each embryo, and the dura was removed. Dorsal horn tissue was isolated according to the “open-book” technique (Peterson and Crain, 1982). The dorsal half of the cord was then incubated in 0.25% trypsin for 30 min, rinsed, mechanically dissociated by trituration, and then plated onto collagen-coated plastic disks affixed over holes in 35 mm culture dishes (recording dishes). Cells were maintained in DMEM (Invitrogen, San Diego, CA) supplemented with 10% fetal bovine serum (FBS) and 10% horse serum for 1 week. After 1 week, the media were switched to DMEM plus 10% horse serum. Cells were used at 10-15 d in culture.

Reverse transcription-PCR screening of dorsal spinal cord cultures for novel UTP-activated receptors. To identify novel UTP-activated P2YRs in dorsal spinal cord cultures, we performed reverse transcription (RT) followed by nested PCR using degenerate primers designed against known UTP-activated P2YRs. RNA was harvested from dorsal spinal cord cultures using the TRIzol method (Invitrogen). Reverse transcription was performed on this RNA with the Superscript reverse transcription kit (Invitrogen) using oligo-dT primers to selectively transcribe mRNA. For nested PCR, two primer pairs were used. The first primer was a degenerate upstream primer, which was designed to the third transmembrane (Tm3) region of P2Y1, 2, 4, and 6. The sequence of this primer was 5′-TCC TC/G/TT TCA CCT GCA T-3′. Two degenerate downstream primers were made, which were designed against regions of high sequence homology in P2YRs activated by UTP, namely P2Y2, 4, and 6. One primer was made to the Tm5 domain and had a sequence of 5′-A/GCA GC/G/TC GC/G/TC GGG CCA TG-3′, whereas the other primer was designed to the Tm6 domain and had a sequence of 5′-GGA AA/GG GCA C/GGA AGC-3′. Poly(A+) cDNA from dorsal spinal cultures was used as the template for a first PCR, which used the Tm3 and Tm6 primer pair. The PCR conditions were 94, 52, and 72°C for 1 min each for 30 cycles with a [Mg2+] of 2 mM. After this reaction, 1 μl of the previous reaction was used as the template for PCR using the Tm3 and Tm5 primer pair. This reaction was run for 30 cycles of 94, 53, and 72°C for 1 min at each temperature with a [Mg2+] of 1.25 mM. The products of this reaction were run on an agarose gel stained with ethidium bromide. DNA bands visualized under UV light were excised from the gel and purified using the QIAquick gel extraction kit (Qiagen, Hilden, Germany). Purified DNA was then ligated into the PCR-blunt II-TOPO vector using the Zero-blunt TOPO cloning kit (Invitrogen), and then sequenced.

Cloning of rat P2Y4. The published sequence of rat P2Y4 does not contain introns (Bogdanov et al., 1998); therefore, to obtain P2Y4 cDNA, we elected to clone the receptor from rat genomic DNA. Genomic DNA was isolated from rat liver and purified using the TRIzol method (Invitrogen). Oligonucleotide primers were designed to regions flanking the start codon and the polyadenylated 3′ end of the sequence. To facilitate the subcloning process, a BamH1 restriction site was designed into the upstream primer (5′-GGA TCC ATG ACC AGT GCA GAA TCC-3′), and an XhoI restriction site was included in the downstream primer (5′-CTC GAG TTA GTT CCC TTC ATA TCC AGC-3′). PCR was performed on rat genomic DNA, and the product of the PCR was run on an agarose gel. A band corresponding to the predicted size was identified and excised from the gel. The DNA contained within this band was purified using the Qiapure method and was ligated into the PCR-blunt II vector (Invitrogen). This was then sequenced to confirm that the PCR product was identical to the published sequence for rat P2Y4 and that it contained the appropriate restriction sites. The introduced restriction sites were used to excise the coding region of P2Y4 from PCR-blunt II, and this was then ligated into the mammalian expression vector pcDNA3 (Invitrogen). The product of this ligation was then sequenced to determine that the sequence was still correct. Bacteria were transformed with rP2Y4-pcDNA3 and were allowed to multiply. The vector DNA was then isolated and purified using the Maxi-prep kit and protocol (Qiagen).

Generation and maintenance of 1321N1 human astrocytoma cell lines stably expressing P2Y1 and P2Y2. Recombinant receptors were expressed in 1321N1 human astrocytoma cells (obtained from the European Collection of Cell Cultures), a cell line that does not express receptors activated by nucleotides (Parr et al., 1994). We used a stable cell line expressing rat P2Y1 (rP2Y1) purinoceptor cDNA (GenBank accession number U22830; from Dr. G. I. Bell, University of Chicago, Chicago, IL) subcloned into the mammalian expression vector pcDNA3, generated as described previously (Fam et al., 2000). To generate a 1321N1 cell line expressing P2Y2, rP2Y2 (GenBank accession number L46165; from Dr. Z.-P. Chen, Robert Wood Johnson Medical School, Pisataway, NJ) was subcloned into the EcoRI-XhoI restriction sites of the mammalian expression vector pcDNA3 (Invitrogen). rP2Y2-pcDNA3 was grown in bacteria and purified and was then transfected into 1321N1 cells using the calcium phosphate method (Sambrook and Russell, 2001). Transfected cells were grown in DMEM supplemented with 10% FBS and 1% penicillin and streptomycin. After 2 d of growth, the transfected cells were split 1:6 into media containing 500 mg/ml G418 (Invitrogen; selection media). Media were exchanged every 2-3 d, and the cells were grown in selection media for 14 d. Isolated colonies of cells demonstrating resistance to G418 were picked and transferred to 24-well plates, where they were grown in selection media to near confluence and then transferred to the recording dishes described above. After 24 hr in recording dishes, cells were loaded with fura-2, and Ca2+ responses to applied UTP were used as an assay to determine cell lines expressing functional P2Y2Rs. In these lines, expression of P2Y2 mRNA was confirmed using RT-PCR. Cell lines found to be expressing P2Y2R were then maintained in normal medium supplemented with 400 mg/ml G418 and split 1:12 every 3-4 d. When required for experiments, cells were split and plated onto recording dishes and were used within 2 d.

To generate fields of cells where P2Y1-1321N1 and P2Y2-1321N1 cells were comingled, equal starting concentrations of P2Y1-1321N1 and P2Y2-1321N1 cells were separately trypsinized and then resuspended in 5 ml of G418 media. Two drops of each resuspended cell line were plated into a 35 mm recording dish, prepared as described above, containing 2 ml of G418 media. Cells were incubated for 48 hr before use. Before initiating a Ca2+ wave in these cells, P2Y1- and P2Y2-expressing cells were identified in each field by brief focal application of the P2Y1R-selective agonist 2-methyl thio ADP (2meSADP) (5 μm) or the P2Y2R-selective agonist UTP (50 μm). No cells tested responded to both agonists.

Although we endeavored to plate cells at a constant density in recording dishes, individual fields often contained differing numbers of cells; thus, it was possible that the density of the cells in each field influenced the rate of Ca2+ wave propagation. We tested this possibility by correlating the mean rate of Ca2+ wave propagation in each field with the number of cells in the field for P2Y1-1321N1, P2Y2-1321N1, and spinal astrocytes. The slope of the best fit regression lines were found to be -0.12 ± 0.1 for P2Y1-1321N1 cells (r2 = 0.04; p = 0.35), -0.22 ± 0.3 for P2Y2-1321N1 cells (r2 = 0.03; p = 0.47), and 0.11 ± 0.6 (r2 = 0.16; p = 0.85) for spinal cord astrocytes. The correlation coefficients calculated indicate that there is no correlation between the rates of Ca2+ wave propagation in P2Y1-1321N1 cells, P2Y2-1321N1 cells, and spinal astrocytes and the cell density in each field.

Transient transfection. Native 1321N1 cells were transiently transfected with rP2Y1-pcDNA3, rP2Y2-pcDNA3, or rP2Y4-pcDNA3 using the Superfect transfection kit (Qiagen) following the protocol specified therein. For cotransfection of two separate plasmids into cells, the plasmid DNAs were mixed together in a 1:1 concentration ratio to the maximum amount of DNA required for optimal transfection efficiency. Transfections were performed using the Superfect transfection kit. In general, ∼25-33% transfection efficiency was attained with the method used in these experiments. Cells were determined to be transfected if they exhibited Ca2+ responses to the appropriate receptor-specific agonists. Transiently transfected cells displayed the normal pharmacological properties of stably transfected cells.

Ca2+imaging. The Ca2+-sensitive fluorophore fura-2 (Molecular Probes, Eugene, OR) was used for measuring [Ca2+]i by ratiometric imaging in both dorsal spinal cultures or 1321N1 cells. All fluorescence measurements were made from subconfluent areas of the dishes so that individual astrocytes or astrocytoma cells could be readily identified. Single dorsal spinal astrocytes were identified using criteria described by Salter and Hicks (1994). Just before recording, cells were incubated at room temperature for 90 min (cultured cells) or 60 min (1321N1 cells) in extracellular recording solution composed of NaCl, 140 mm; KCl, 5.4 mm; CaCl2, 1.3 mm; HEPES, 10 mm; glucose, 33 mm; and tetrodotoxin, 0.5 μm, pH 7.35, osmolarity 315-320 mOsm, which had been supplemented with bovine serum albumin (BSA, 0.5%) and fura-2 AM (2 μm). Subsequently, the culture dish was thoroughly rinsed with extracellular solution lacking fura-2 AM and BSA and was mounted on an inverted microscope (Diaphot-TMD; Nikon). To avoid neuron-astrocyte signaling in dorsal spinal cord cultures, the areas chosen were free from neurons. When required, cultured cells were bathed in extracellular solution with no added Ca2+ and supplemented with 100 μm EGTA, referred to as Ca2+-free extracellular solution. Cultures were viewed using a 40× CF epifluorescence Fluor objective lens. Recordings were made at room temperature (20-22°C).

Recording of Ca2+ waves was done by ratiometric imaging. Excitation light at 340 and 380 nm was generated by a xenon arc lamp and passed through a high-speed, computer-controlled, variable-wavelength monochromator. This light was transmitted to the recording dish via a fiberoptic cable. Emitted light was directed through a 510 nm bandpass filter and was detected by an intensified CCD camera. The CCD camera black level was set to >1% to maximize the dynamic range of the instrument. Images were acquired by computer at a rate of ∼2.5/sec and were stored on a hard disk. Hardware and software for imaging were from Photon Technology International (Lawrenceville, NJ).

Image data were analyzed off-line. The first image in each image set was used as a template for designating each cell as a region of interest within the image. Each 340 nm image was divided, on a pixel-by-pixel basis, by the corresponding 380 nm image, producing a ratio image. Averaged values of the ratios within each region of interest were plotted as a function of time. No attempt was made to convert ratio data from images to [Ca2+]i.

Drug application. P2YR agonists were dissolved in extracellular solution. Agonists were applied to fields of astrocytoma cells by pressure ejection from a pipette located ∼50-70 μm from the nearest cell to avoid pressure-induced stretching of cell membranes. All other drugs were dissolved in extracellular solution and were applied directly in the bath.

Measurement of latency of responses to exogenous ATP or ADP. When determining the latency of the responses of individual cells to applications of ATP or ADP, these agonists were applied from a micropipette, the tip of which was a fixed distance (70 μm) from each cell. ATP or ADP was applied continuously until a peak increase in [Ca2+]i was reached or to a maximum of 60 sec. We measured the time (t1/2) from the onset of drug application to the time the Ca2+ response in the stimulated cell reached 50% of its peak.

Stimulation of Ca2+waves. Ca2+ waves were evoked by mechanical stimulation of an individual astrocyte or 1321N1 cell. A single cell was briefly touched under visual control with the tip (3-5 μm diameter) of a fire-polished glass pipette lowered gradually from a height of ∼3 μm above the cell. The mechanical stimulation was done regularly at 10 min intervals. Pharmacological manipulations were only performed in cases in which two or more Ca2+ waves were reliably evoked beforehand.

Analysis of data. To determine the rate of Ca2+ wave propagation in P2Y1-1321N1 cells, P2Y2-1321N1 cells, and dorsal spinal cultures, for each cell engaged by the Ca2+ wave, the distance, in micrometers, between the stimulated and target cells was measured and divided by the interval between the onset of the elevation in [Ca2+]i in the stimulated cell and the onset of the elevation in [Ca2+]i in the responding cell, giving a value expressed as micrometers per second. Statistical analysis was performed on grouped data from the total number of cells from each experimental group using an independent t test; p < 0.05 was considered to indicate a statistically significant difference.

Analysis of pharmacological data. Concentration inhibition data were collected for suramin and pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS) in P2Y1-1321N1, P2Y2-1321N1, and spinal astrocytes. Inhibition curves were constructed by fitting the mean response amplitude at each concentration with the equation E = E0/(1 + ([antagonist]/[IC50])n), where E0 was the response amplitude in the absence of antagonist.

Source of reagents. 2meSADP, ADP, and UTP were from Research Biochemicals (Natick, MA). Apyrase (grade III) and all other reagents, except where indicated above, were from Sigma. We confirmed that the apyrase was active by using a luciferin-luciferase assay.

Results

P2Y2 mediates UTP-evoked Ca2+ responses in spinal astrocytes

Because the pharmacological profile of UTP-activated Ca2+ responses in spinal dorsal astrocytes (Ho et al., 1995) was reported to be distinct from the profiles that have been described for the three cloned P2YR subtypes activated by UTP, P2Y2, P2Y4, and P2Y6 (Charlton et al., 1996; King et al., 1998), we screened for the potential expression of novel UTP-activated receptors by these astrocytes by using nested RT-PCR to amplify poly(A+) RNA from dorsal spinal cultures. We used degenerate primers to highly conserved regions in P2Y2, P2Y4, and P2Y6; two downstream primers were made to regions encoding the fifth and the sixth transmembrane domains, and a single upstream primer was made to a region of the third transmembrane domain that is conserved in P2Y2, P2Y4, and P2Y6 as well as in the other known rat P2YRs. This strategy yielded only two products (Fig. 1a, top), which, when sequenced, were found to correspond to a 203 bp fragment of P2Y2 and a 314 bp fragment of P2Y4. The size of the P2Y2 fragment was 108 bp smaller than predicted, likely because of formation of a cDNA hairpin loop (see Fig. 1 legend). Separate RT-PCR with P2Y2-specific primers (Fig. 1a, bottom) confirmed the expression of mRNA for P2Y2.

Figure 1.

Figure 1.

Spinal astrocytes functionally express P2Y2 but not P2Y4. a, Top, Result of nested PCR of cDNA from spinal cord cultures and 1321N1 cells expressing P2Y2 using degenerate oligonucleotide primers. +, The template cDNA was generated from an RT reaction, which included the enzyme reverse transcriptase; -, the template for the PCR was taken from a control RT reaction in which no reverse transcriptase was added. Two bands of 314 and 203 bp were detected, which corresponded to P2Y4 and a fragment of P2Y2. The P2Y2R fragment was 108 bp shorter than the expected size based on the published sequence. In other experiments, when 5% DMSO was included in the PCR mixture, we obtained the full-length of the P2Y2 fragment (Varadaraj and Skinner, 1994) (data not shown). Bottom, Using specific primers, a separate P2Y2 fragment was amplified from spinal cord cultures. This suggested that under the PCR conditions for the experiments shown in a, P2Y2 cDNA likely forms a hairpin loop, which is skipped by the DNA polymerase. b-d, f, Traces of 340/380 fura-2 emission ratios; each trace is from an individual cell. Recordings were from a spinal astrocyte (b) or from 1321N1 cells transfected with P2Y2 (c), P2Y4 (d), or P2Y2 and P2Y4 (f). The short bars below each trace indicate the periods of application of UTP (10 μm). Cells were tested with an ascending series of concentrations of bath-applied suramin; the concentration is indicated below each application of UTP. e, Suramin concentration-inhibition curves of UTP-evoked responses of spinal astrocytes and 1321N1 cells expressing either P2Y2 or P2Y4 receptors. Each curve is the best fit of the means to the logistic equation 100/(1 + ([suramin]/IC50)slope). The calculated IC50 for suramin at spinal astrocytes was 7 ± 1 μm (n = 5 cells), and at 1321N1 cells expressing P2Y2 receptors, it was 23 ± 9 μm (n = 5 cells). For 1321N1 cells expressing P2Y4 receptors, suramin was ineffective (n = 4 cells).

Because we found no evidence for expression of P2Y6 or of potentially novel UTP-activated P2YRs, and because the previously reported pharmacological characterization of recombinant UTP-activated receptors was done using the human P2Y homologs (Charlton et al., 1996), which show ∼89% sequence identity with rat P2Y2Rs and P2Y4Rs, we wondered whether Ca2+ responses mediated by P2Y2Rs or P2Y4Rs from rat might have pharmacological properties, not previously recognized, that would match the properties of UTP-activated Ca2+ responses in spinal astrocytes. The potentially distinguishing pharmacological properties of UTP-evoked responses in astrocytes (Ho et al., 1995) were blockade by suramin and PPADS. Therefore we compared the effects of suramin and PPADS on responses to UTP in spinal astrocytes versus UTP-evoked responses mediated by recombinant rat P2Y2Rs and rat P2Y4Rs expressed in 1321N1 cells, an astrocytoma cell line that lacks endogenous purinoceptors (Parr et al., 1994). Brief, localized applications of UTP (100 μm, 1-5 sec) evoked reproducible Ca2+ responses characterized by a transient rise in [Ca2+]i in individual astrocytes (Fig. 1b) or 1321N1 cells expressing P2Y2Rs (Fig. 1c) or P2Y4Rs (Fig. 1d). These Ca2+ responses were unaffected by removing extracellular Ca2+ (data not shown), indicating that the responses were mediated by release of Ca2+ from intracellular stores.

UTP-evoked responses of dorsal spinal astrocytes showed a concentration-dependent blockade by suramin (Fig. 1b,e; n = 5 cells), as did Ca2+ responses mediated by rat P2Y2Rs (Fig. 1c,e; n = 5 cells). On the other hand, Ca2+ responses mediated by rat P2Y4Rs were not significantly suppressed by suramin at concentrations up to 100 μm (Fig. 1d,e; n = 4 cells). The resistance of responses mediated by P2Y4Rs to suramin implies that P2Y4Rs alone could not account for the UTP-stimulated Ca2+ responses in the astrocytes. To examine whether coexpression of rat P2Y2Rs and rat P2Y4Rs might produce UTP-evoked Ca2+ responses that are sensitive to suramin, for example, by potential heteromultimerization of P2Y2Rs and P2Y4Rs, we coexpressed these receptors in 1321N1 cells. We found that the Ca2+ responses activated by UTP were depressed in suramin in a concentration-dependent manner (Fig. 1f; n = 5 cells), but even at the highest concentration of suramin tested (100 μm), there was a large residual Ca2+ response, with an amplitude approximately half that of the control responses. Thus, with cells coexpressing P2Y2Rs and P2Y4Rs there was a suramin-resistant component that was not seen with the UTP-evoked Ca2+ responses of the spinal astrocytes. Therefore, the Ca2+ responses to UTP in the astrocytes could not be accounted for by expression of P2Y4Rs either alone or together with P2Y2Rs. Furthermore, these results indicated that there is no functional expression of P2Y4Rs by dorsal spinal astrocytes.

These results suggest that Ca2+ responses stimulated by UTP in spinal astrocytes might be mediated by P2Y2Rs. In astrocytes, the UTP-evoked Ca2+ responses show concentration-dependent blockade by PPADS (Fig. 2a) (Ho et al., 1995). However, PPADS is reported to have no effect on responses mediated by human P2Y2Rs (Charlton et al., 1996) in a study that examined the effect of PPADS on phospholipase C activation. Presently, we examined the effect of PPADS on Ca2+ responses mediated by rat P2Y2Rs stably transfected into 1321N1 cells (P2Y2-1321N1 cells). We found that the Ca2+ responses evoked by UTP (10 μm) in P2Y2-1321N1 cells were blocked by bath applying PPADS (Fig. 2b). The blockade by PPADS was concentration-dependent, with an IC50 of 24 ± 0.7 μm (n = 10 cells; Fig. 2c). In contrast, PPADS (50 μm) had no effect on Ca2+ responses evoked by stimulating muscarinic acetylcholine receptors, which are endogenously expressed in 1321N1 cells (Fig. 2d), indicating that the effect of PPADS on P2Y2R-mediated Ca2+ responses was not attributable to a nonspecific action of PPADS on intracellular Ca2+ signaling. Hence, Ca2+ responses mediated by rat P2Y2Rs expressed heterologously, as well as by the endogenous UTP-activated receptor in spinal astrocytes, are antagonized by PPADS. Thus, from the convergence of our molecular and pharmacological findings, we conclude that the receptor mediating the Ca2+ responses of rat dorsal spinal astrocytes to UTP is the P2Y2R.

Figure 2.

Figure 2.

PPADS blocks both the Ca2+ responses of P2Y2-1321N1 cells and spinal astrocytes to UTP but not to carbachol. a, b, Representative traces of 340/380 fura-2 emission ratios from a single P2Y2-1321N1 cell and from a dorsal spinal astrocyte evoked by 10 μm UTP in the presence of increasing concentrations of PPADS. c, Concentration-inhibition curve for PPADS at P2Y2Rs. The curve is the logistic equation best fitted to the means. The calculated IC50 for PPADS at the P2Y2 receptor was 24 ± 0.7 μm (n = 10 cells). d, Untransfected 1321N1 cells were challenged with exogenously applied carbachol (100 μm), stimulating endogenous muscarinic acetylcholine receptors. Responses to carbachol were unaffected by PPADS but were blocked by the muscarinic receptor antagonist atropine (10 μm).

Ca2+ wave propagation by native and recombinant P2Y2 receptors

In spinal astrocyte networks, Ca2+ wave propagation is suppressed by the selective P2Y1 receptor antagonist A3P5PS, and the blockade of Ca2+ waves that persist in adenosine 3′-phosphate-5′-phosphosulfate (A3P5PS) by suramin imply that the Ca2+ waves require activation of a subtype of P2YR in addition to P2Y1 (Fam et al., 2000). In the present study, we found that suramin discriminates between the two non-P2Y1R subtypes for which mRNA was detected: suramin blocks Ca2+ responses mediated by P2Y2Rs, but those mediated by P2Y4Rs are resistant to suramin (Fig. 1). These findings imply that, in the spinal astrocyte network, P2Y2R activation mediates the component of the Ca2+ wave that is not propagated via P2Y1Rs.

To determine whether P2Y2Rs are sufficient to support Ca2+ waves, we investigated responses of P2Y2-1321N1 cells to single-cell mechanical stimulation, which in spinal astrocytes initiates Ca2+ waves (Fam et al., 2000). In P2Y2-1321N1 cells, mechanical stimulation of one cell resulted in a rise in [Ca2+]i in that cell, which was followed by a wave of increased [Ca2+]i that spread concentrically to cells throughout the field (Fig. 3). In nontransfected 1321N1 cells, mechanical stimulation increased [Ca2+]i in the stimulated cell; however, there was no change in [Ca2+]i in neighboring cells (Fam et al., 2000). Moreover, the spread of the Ca2+ waves in P2Y2-1321N1 cells was prevented by bath applying suramin.

Figure 3.

Figure 3.

Ca2+ waves propagate in 1321N1 cells expressing P2Y2. cDNA encoding rat P2Y2 was transiently transfected into 1321N1 cells. Cells expressing P2Y2 were identified by focal application of UTP (50 μm) and are labeled with yellow circles (top panel). A Ca2+ wave was initiated by touching the cell indicated by the arrow (which did not respond to exogenous UTP) at t = 0 sec. The five subsequent panels show 340/380 ratiometric images of the cells before stimulation (t = 0) and at 5, 10, 15, and 20 sec after stimulation. Scale bar, 20 μm in this and all subsequent figures. Results are representative of nine fields of cells in three transfections.

To determine whether expression of P2Y2Rs permits the spread, as opposed to the initiation, of the Ca2+ waves, we transiently transfected 1321N1 cells with P2Y2Rs so that transfected and nontransfected cells were intermingled. The transfection conditions were set such that only approximately one-quarter of the cells expressed functional P2Y2Rs, as indicated by rapid Ca2+ responses of these cells to focal application of UTP (50 μm, 2 sec duration; Fig. 3). We found that mechanically stimulating an individual cell evoked a Ca2+ wave that spread only to those cells that responded to UTP (58 cells in nine fields); the Ca2+ wave did not engage cells that did not respond to UTP. Mechanical stimulation of cells responsive to UTP initiated Ca2+ waves, as did stimulation of cells that were themselves unresponsive to UTP (Fig. 3). Thus, Ca2+ waves were initiated by mechanical stimulation regardless of whether the stimulated cell itself did or did not express P2Y2Rs. These findings imply that expression of P2Y2Rs is sufficient to permit the spread of Ca2+ waves in cells that normally do not express this receptor, but P2Y2R expression is not required for the initiation of Ca2+ waves. Taking these results together, we conclude that in the spinal astrocyte network, a component of Ca2+ waves is mediated by endogenous P2Y2Rs.

Differing rates of propagation of Ca2+ waves mediated by P2Y1 versus P2Y2 receptors

In characterizing the properties of Ca2+ waves mediated by P2Y1Rs and P2Y2Rs, we examined the rate at which the Ca2+ waves spread. We measured the time interval between the onset of the [Ca2+]i change in the stimulated cell and the onset of the rise in [Ca2+]i in the target cell. The rate of Ca2+ wave propagation to each individual cell that participated in the Ca2+ wave was then calculated by dividing the distance between the target cell and the stimulated cell by the measured time interval. In the spinal astrocyte network, where both P2Y1Rs and P2Y2Rs are expressed, we found that the mean rate of Ca2+ wave propagation was 19.4 ± 0.8 μm/sec (n = 149 cells in 23 fields). To determine separately the rate of spread of Ca2+ waves mediated by the individual subtypes of P2YRs, we used cell lines stably expressing P2Y1 (P2Y1-1321N1) or P2Y2 (P2Y2-1321N1) receptors. In P2Y1-1321N1 cells, the mean rate of Ca2+ wave propagation was found to be 7.6 ± 0.3 μm/sec (n = 201 cells in 21 fields). In contrast, in P2Y2-1321N1 cells, the mean rate of propagation was 17.1 ± 0.7 μm/sec (n = 175 cells in 19 fields; Fig. 4), which was significantly greater than the rate in P2Y1-1321N1 cells (p < 0.0001, Student's t test).

Figure 4.

Figure 4.

Ca2+ waves propagate at a greater rate in P2Y2-1321N1 cells than in P2Y1-1321N1 cells. a, Representative example of a Ca2+ wave in a field in which P2Y1-1321N1 cells were mixed with P2Y2-1321N1 cells. P2Y1-1321N1 cells were identified by observing [Ca2+]i after application of 2meSADP (5 μm), whereas P2Y2-1321N1 cells were identified by focal application of UTP (50 μm). No cells responded to both agonists. Cells that responded to UTP are circled in yellow. A Ca2+ wave was stimulated by touching the cell labeled with the arrow. The subsequent panels show the spread of the Ca2+ wave at 5, 10, 15, and 20 sec after stimulation. b, c, Representative traces of the 340/380 fura-2 emission ratios in two separate fields of cells after stimulation of cell 1 in each field at the time indicated by the arrow. P2Y1-1321N1 cells are shown in b; P2Y2-1321N1 cells are shown in c. d, Histogram illustrating the distribution of the rates of Ca2+ wave propagation in P2Y1-1321N1 and P2Y2-1321N1 cells. The calculated rates of Ca2+ wave propagation in P2Y1-1321N1 and P2Y2-1321N1 were grouped in 1 sec bins. Each bin represents the number of cells to which Ca2+ waves propagated at that particular speed. e, Mean rate of Ca2+ wave propagation in P2Y1-1321N1 cells compared with the mean rate of Ca2+ wave propagation in P2Y2-1321N1 cells (p < 0.001; n = 210 cells in 21 fields of P2Y1-1321N1 cells and n = 175 cells in 19 fields of P2Y2-1321N1 cells).

A possible explanation for the difference in the rates of Ca2+ wave propagation between P2Y1-1321N1 and P2Y2-1321N1 cells was clonal variation in the cell lines expressing the receptors. We investigated this possibility by measuring the rates of Ca2+ wave propagation in 1321N1 cells transiently expressing P2Y1 or P2Y2 so that there was no clonal selection. We found that in cells in which P2Y1 was transiently expressed, the mean rate of Ca2+ wave propagation was 5.9 ± 0.7 μm/sec (n = 20 cells from six fields from three separate transfections). In cells transiently expressing P2Y2Rs, the mean rate of Ca2+ wave propagation was 15.6 ± 0.9 μm/sec (n = 58 cells from nine fields from three separate transfections), which was significantly faster than the rate of Ca2+ wave propagation with transient expression of P2Y1Rs (p < 0.0001). The rate of propagation of Ca2+ waves through the cells transiently transfected with P2Y1 was not significantly different from the rate in the stable cell line (p = 0.11). Similarly, the rate of propagation of the Ca2+ wave through cells transiently expressing P2Y2Rs was not different from the rate of propagation through P2Y2-1321N1 cells (p = 0.23). Thus, clonal variation cannot account for the difference in the rate of propagation of Ca2+ waves in P2Y1-1321N1 versus P2Y2-1321N1 cells. Hence, with either transient or stable expression of the receptors, Ca2+ waves mediated by P2Y2Rs propagate more rapidly than do those mediated by P2Y1Rs.

P2YR-mediated Ca2+ waves are initiated through release of ATP from the stimulated cell, diffusion of ATP to target cells, and the activation of P2YRs on those cells, leading to downstream release of stored intracellular Ca2+. The difference in the rate of Ca2+ wave propagation between P2Y1- and P2Y2-expressing cell lines might be a result of differences in any of these steps; therefore, we explored each step separately, as described in the following sections.

Difference in rate of Ca2+ wave propagation is independent of P2Y receptor expression on the cell initiating the wave

It is possible that the rate of Ca2+ wave propagation in P2Y2-1321N1 cells was calculated to be faster than that in P2Y1-1321N1 cells because the initiation of the waves was more rapid in P2Y2-1321N1 cells. To examine this possibility, we intermingled P2Y1-1321N1 with P2Y2-1321N1 cells and simultaneously recorded P2Y1- and P2Y2-mediated Ca2+ waves initiated by stimulating a single cell expressing either type of receptor. We found that when a cell expressing P2Y1 was stimulated, the rate of Ca2+ wave propagation to other P2Y1-expressing cells was 7.5 ± 0.8 μm/sec, whereas the rate of propagation to P2Y2-expressing cells was 16.3 ± 1.8 μm/sec (n = 43 and 53 cells, respectively, in 12 fields; p < 0.001). Conversely, when a cell expressing P2Y2Rs was stimulated, the rate of Ca2+ wave propagation to P2Y1-expressing cells was 7.5 ± 0.9 versus 16.7 ± 0.9 μm/sec in P2Y2-expressing cells (n = 37 and 43 cells, respectively, in 10 fields; p < 0.001). Thus, regardless of which subtype of P2YR was expressed in the cell from which the Ca2+ wave originated, the rate at which the Ca2+ waves spread in P2Y2-expressing cells was significantly faster than that in P2Y1-expressing cells.

Ectonucleotidase inhibitor ARL 67156 has no effect on Ca2+ wave propagation

ATP released from a stimulated astrocyte diffuses through the extracellular space to reach and activate P2YRs on surrounding cells. In the extracellular environment, ATP may be hydrolyzed by ectonucleotidases, ubiquitous surface-bound enzymes that metabolize extracellular nucleotides (Zimmermann, 2000). We considered that extracellular hydrolysis may participate in Ca2+ wave propagation because P2Y2Rs are selectively activated by ATP, whereas P2Y1Rs are preferentially activated by ADP (Fig. 5a) (North and Barnard, 1997). We thus hypothesized that Ca2+ waves mediated via activation of P2Y1Rs may require the conversion of ATP to ADP to activate the receptors, in which case the slower rate of Ca2+ wave propagation to cells expressing P2Y1Rs might be attributable to such an additional enzymatic step.

Figure 5.

Figure 5.

Ectonucleotidase inhibitor ARL 67156 has no effect on Ca2+ wave propagation. a Concentration-response curves for ADP (triangles) and ATP (squares) at P2Y1-1321N1 cells and for ATP (circles) at P2Y2-1321N1 cells. Each data point is the mean ± SEM of the response to the applied agonist at each concentration for n = 5-10 cells. Each curve is the best fit of the means to the logistic equation 100/(1 + (EC50/[agonist])slope). The calculated EC50 values are as follows: P2Y1-ATP, 183 ± 53 nm; P2Y1-ADP, 38 ± 14 nm; P2Y2-ATP, 109 ± 21 nm. because ADP is more potent than ATP at the P2Y1 receptor, we hypothesized that an ectonucleotidase was required to metabolize ATP to ATP for P2Y1-expressing cells to be engaged by the Ca2+ wave. b, Comparison of the rates of Ca2+ wave propagation in intermingled P2Y1-1321N1 and P2Y2-1321N1 cells before and during incubation with the ectonucleotidase inhibitor ARL 67156 (n = 12 fields). c, Comparison of the percentages of P2Y1-1321N1 and P2Y2-1321N1 cells that are engaged by the Ca2+ wave before and during incubation with ARL 67156 (n = 12 fields).

We therefore examined the effect of ARL 67156, a selective ectonucleotidase inhibitor (Crack et al., 1995; Westfall et al., 1997), on the rate of spread of Ca2+ waves in P2Y1-1321N1 and P2Y2-1321N1 cells. If Ca2+ wave propagation via P2Y1Rs requires that ATP be hydrolyzed to ADP, then inhibiting ectonucleotidase activity would be predicted to prevent Ca2+ waves in P2Y1-1321N1 cells. However, we found that Ca2+ waves persisted in P2Y1-1321N1 cells during bath application of ARL 67156 (100 μm; Fig. 5b,c), at a concentration of ARL that causes 70% inhibition of ATP dephosphorylation by human red blood cells (Crack et al., 1995). In the presence of ARL 67156, the rate of Ca2+ wave propagation in P2Y1-expressing cells was 7.7 ± 0.7 μm/sec versus the control rate of 9.1 ± 1.1 μm/sec (n = 37 cells in 12 fields; p > 0.5). ARL 67156 also had no effect on the rate of Ca2+ wave propagation in P2Y2-1321N1 cells: in ARL 67156, the rate was 17.1 ± 1.5 μm/sec versus the control rate of 15.4 ± 0.9 μm/sec (n = 49 cells in 12 fields; p > 0.5). Thus, we find no evidence that ectonucleotidase activity participates in or regulates the rate of propagation of Ca2+ waves mediated by P2Y1Rs or P2Y2Rs expressed in 1321N1 cells.

ATP-evoked Ca2+ responses mediated by P2Y1 receptors are generated more slowly than those mediated by P2Y2 receptors

Because there was no evidence for extracellular conversion of ATP to ADP, P2Y1Rs and P2Y2Rs may be exposed to comparable concentrations of ATP during the passage of a Ca2+ wave. Thus, the remaining potential explanation for the faster rate of Ca2+ wave propagation via P2Y2Rs is that these receptors may transduce the extracellular ATP signal into a change in [Ca2+]i more rapidly than do P2Y1Rs. Therefore, we examined the time course of Ca2+ responses to ATP (0.1-10 μm) applied by pressure ejection directly onto individual cells expressing either P2Y1Rs or P2Y2Rs. ATP was applied continuously until the rise in [Ca2+]i had peaked, and we measured the time from the start of the application to when [Ca2+]i reached half of the peak value (t1/2).

We found that t1/2 decreased with increasing concentrations of ATP for Ca2+ responses mediated by P2Y1Rs or P2Y2Rs. For 100 nm ATP, t1/2 for P2Y1R-mediated responses was not different from that of P2Y2R-mediated responses; however, at all higher concentrations of ATP tested, we found that t1/2 for P2Y1R-mediated Ca2+ responses was significantly longer than that for P2Y2R-mediated responses (Fig. 6a,b,d). Thus, at ATP concentrations >100 nm, P2Y1Rs generated Ca2+ responses more slowly than did P2Y2Rs. The difference in t1/2 persisted even when we accounted for the slight difference in EC50 values for ATP at the two receptors (Fig. 6d, inset); thus, the difference in rate of signal transduction at greater than the EC50 values was not attributable to the difference in potency of ATP at P2Y1 versus P2Y2Rs. We wondered whether the slow rate of P2Y1-mediated Ca2+ responses is an intrinsic characteristic of responses mediated by this subtype of P2YR. To address this, we compared Ca2+ responses of P2Y1-1321N1 cells evoked by ADP with those observed when P2Y1-1321N1 cells were stimulated with ATP (Fig. 6e). As with responses to ATP, the t1/2 for P2Y1-mediated Ca2+ responses evoked by ADP was inversely related to agonist concentration. However, at each concentration tested, the t1/2 for responses evoked by ADP was significantly less than t1/2 for responses to ATP. ADP is approximately five times more potent at P2Y1Rs than is ATP (Fig. 5a), but even when we corrected for this difference in potency, ADP-evoked responses were faster than were responses to ATP at concentrations above the respective EC50 (Fig. 6e, inset). Thus, the slow rate of signaling of P2Y1Rs when stimulated with ATP is not an inherent characteristic of the receptors themselves because the signaling was much faster when the receptors were stimulated with ADP. Indeed, with ADP stimulation, the t1/2 values for P2Y1 receptor-mediated Ca2+ responses were comparable with t1/2 values for P2Y2-mediated Ca2+ responses with ATP stimulation (Fig. 6c).

Figure 6.

Figure 6.

P2Y1-expressing cells take longer to generate an elevation in [Ca2+]i than P2Y2-expressing cells when stimulated with ATP. ATP or ADP, at varying concentrations, were applied by picospritzer from a fixed distance (70 μm) onto single astrocytoma cells expressing either P2Y1 or P2Y2. a, b, Representative normalized examples of responses from single P2Y1-1321N1- and P2Y2-1321N1-expressing cells, respectively, when stimulated with ATP at concentrations of 100 and 500 nm and 1 and 10 μm. c, Comparison of the time to half-maximal response (t1/2) for ADP at P2Y1-1321N1 cells to that of ATP at P2Y2-1321N1 cells when each t1/2 is normalized to the appropriate EC50. d, Comparison of the t1/2 for each concentration of ATP applied to either P2Y1-1321N1 cells (squares) or P2Y2-1321N1 cells (circles). Inset, t1/2 normalized to the EC50 values for ATP at the P2Y1 and P2Y2 receptors. Because ADP is a more potent agonist than ATP at the P2Y1 receptor, we investigated t1/2 for varying concentrations of ADP applied to P2Y1-1321N1 cells. e, Comparison of the t1/2 for each concentration of ADP applied to P2Y1-1321N1 cells with the t1/2 for ATP for the same concentrations of ATP also applied to P2Y1-1321N1 cells. Inset, t1/2 normalized to the EC50 values for ATP and ADP at the P2Y1 receptor.

These data show that the rate at which P2Y1Rs and P2Y2Rs respond to extracellular nucleotides is both agonist- and concentration-dependent. When P2Y1Rs and P2Y2Rs are stimulated with equal concentrations of ATP, P2Y1Rs are slower to generate a rise in [Ca2+]i than are P2Y2Rs; however, stimulation of P2Y1 with ADP evokes a rapid elevation in [Ca2+]i.

Apyrase increases the rate of propagation of Ca2+ waves to P2Y1-expressing cells but prevents the spread of Ca2+ waves to P2Y2-expressing cells

Taking the results above together, we infer that the spread of Ca2+ waves mediated via activation of P2Y1Rs is slower than that via P2Y2Rs primarily because P2Y1Rs transduce extracellular ATP signals more slowly than do P2Y2Rs. Nevertheless, because P2Y1R-mediated Ca2+ responses were rapid when the receptors were activated by ADP (see above), we predicted that the rate of Ca2+ wave propagation between P2Y1-expressing cells should increase if the waves were to propagate using ADP instead of ATP as the extracellular messenger. To test this prediction, we facilitated the extracellular conversion of ATP to ADP by bath applying the nucleotidase apyrase. For this, we used a grade of apyrase that contains predominantly ATPase activity with lesser ADPase activity and only trace AMPase activity (grade III apyrase; Sigma) to minimize degradation of ADP but enhance hydrolysis of ATP.

For these experiments, P2Y1-1321N1 cells were intermingled with P2Y2-1321N1 cells. We found that during bath application of apyrase (30 U/ml), the rate of Ca2+ wave propagation in P2Y1-1321N1 cells increased from 8.6 ± 1.1 to 21.2 ± 1.4 μm/sec (p < 0.001; Fig. 7a-c,e). In addition, the proportion of P2Y1-expressing cells that participated in the Ca2+ waves increased from 36% of the cells per field under control conditions to 77% of the cells during apyrase application (control, n = 19 cells; apyrase, n = 41 cells in seven fields; Fig. 7d). As a positive control for the activity of the apyrase, we predicted that the spread of Ca2+ waves in P2Y2-1321N1 cells should be suppressed by the nucleotidase because ADP and AMP are inactive at P2Y2Rs (North and Barnard, 1997). During apyrase application, 5% of P2Y2-expressing cells participated in the Ca2+ wave in contrast to 61% of P2Y2-expressing cells that participated in the control Ca2+ wave (control wave, n = 22 cells; apyrase, n = 2 cells in seven fields; Fig. 7d). In the presence of apyrase, the rate of Ca2+ wave propagation for the P2Y2-1321N1 cells decreased from 19.4 μm/sec in the control wave to 8.7 μm/sec for the two cells that were engaged by the wave in apyrase (Fig. 7e).

Figure 7.

Figure 7.

Apyrase blocks Ca2+ wave propagation in P2Y2-1321N1 cells, whereas it increases the rate of Ca2+ wave propagation in P2Y1-1321N1 cells. a, Field of cells in which cells stably expressing P2Y1 were mixed with cells stably expressing P2Y2. P2Y1-expressing cells were identified by a change in [Ca2+]i after focal application of 2meSADP (5 μm), whereas P2Y2-expressing cells were identified by focal application of UTP (50 μm) and are labeled with yellow circles (top row). A control Ca2+ wave was stimulated at t = 0 sec by touching the indicated cell. The spread of the control wave at 5, 10, 15, and 20 sec after stimulation is shown. The second column shows the spread of the Ca2+ wave in the same field of cells after incubation with apyrase (30 U/ml) for 15 min (representative of 7 separate experiments). b, c, Representative traces of the 340/380 fura-2 emission ratios from individual cells in the experiment shown above during a control Ca2+ wave (b) and during a Ca2+ wave in apyrase (c) (P2Y1-1321N1 cells are shown in blue, and P2Y2-1321N1 cells are shown in red). d, Comparison of the percentage of P2Y1-1321N1 and P2Y2-1321N1 cells that are engaged in control Ca2+ waves and in Ca2+ waves in the presence of apyrase. e, Comparison of the mean rate of Ca2+ wave propagation in P2Y1-1321N1 and P2Y2-1321N1 cells before and during incubation with apyrase.

That apyrase suppresses the number of P2Y2-expressing cells that are engaged by the Ca2+ wave is readily predicted because this nucleotidase degrades extracellular ATP, the chemical intermediary of the waves. The observation that Ca2+ waves mediated by P2Y1Rs are facilitated by apyrase, which may seem paradoxical on the basis that apyrase degrades ATP, is nonetheless also readily predicted on the basis that ADP is a more potent ligand at P2Y1Rs than is ATP and on the basis of our finding, described above, that the speed at which P2Y1Rs generate Ca2+ responses is greater when the receptors are activated by ADP than by ATP. Thus, apyrase can be used to differentiate endogenous responses mediated by P2Y2Rs versus P2Y1Rs: it selectively suppresses activation of P2Y2Rs by degrading ATP but maintains activation of P2Y1Rs, presumably by producing ADP.

Ca2+waves in 1321N1 cells coexpressing P2Y1 and P2Y2 receptors

In spinal cord astrocytes, the majority of cells express both P2Y1Rs and P2Y2Rs (Ho et al., 1995), whereas in the experiments described above, we expressed either P2Y1Rs or P2Y2Rs in individual cells. To determine whether expression of both receptor subtypes in individual cells affects the characteristics of Ca2+ waves, we cotransfected these receptors together into 1321N1 cells. In these experiments ∼30% of cells responded to either ADP or UTP. Of these cells, 80% were found to respond both to ADP and to UTP, indicating that they functionally expressed both P2Y1Rs and P2Y2Rs; 13% responded only to ADP, whereas 7% responded to UTP but not ADP. In the 13% of cells that responded only to ADP the mean rate of Ca2+ wave propagation was 8.1 ± 1.7 μm/sec (n = 9 cells), whereas in cells that responded only to UTP, the mean rate was 17.9 ± 2.7 μm/sec (n = 5 cells). These rates of propagation were significantly different from one another (p < 0.01) but were similar to the rates of Ca2+ wave propagation observed in the 1321N1 cells that stably expressed either P2Y1Rs or P2Y2Rs, respectively (compare with above).

In the cells that responded both to ADP and to UTP, we found that the mean rate of Ca2+ wave propagation was 11.7 ± 0.7 μm/sec (n = 56 cells). To determine the effect of selectively blocking P2Y1Rs on Ca2+ wave propagation, we bath applied A3P5PS (100 μm). A3P5PS prevented Ca2+ waves in 36% of cells responding to both ADP and UTP (control, n = 14 cells in four fields; during A3P5PS, n = 9 cells), indicating that P2Y1Rs were necessary for Ca2+ wave propagation in these cells. In these cells, the rate of Ca2+ wave propagation before applying A3P5PS was 7.7 ± 1.1 μm/sec. On the other hand, for cells in which Ca2+ waves persisted in A3P5PS, the propagation rate before applying this P2Y1R antagonist was 13.1 ± 2.4 μm/sec. Moreover, the rate of Ca2+ wave propagation was unaffected in these cells during A3P5PS (rate, 15.5 ± 1.7 μm/sec; p > 0.1 vs before A3P5PS).

To determine whether P2Y2Rs are required for Ca2+ wave propagation in cells expressing both P2Y1Rs and P2Y2Rs, we investigated the effect of apyrase on Ca2+ waves. We examined 11 cells expressing P2Y1Rs and P2Y2Rs in two fields and found that propagation of Ca2+ waves to only two of these cells was blocked during bath application of apyrase. The Ca2+ waves that persisted during apyrase were suppressed by A3P5PS (100 μm; data not shown), indicating that these waves depended on P2Y1Rs. The rate of Ca2+ wave propagation during apyrase application was 18.1 ± 2.1 μm/sec, which was significantly greater than the rate of P2Y1R-dependent Ca2+ waves without apyrase (7.7 ± 1.1 μm/sec; p < 0.05), as predicted from the effect of apyrase on Ca2+ wave propagation in P2Y1-1321N1 cells.

Thus, with coexpression of P2Y1Rs and P2Y2Rs, the requirement of the two receptor subtypes for the propagation of Ca2+ waves varies on a cell-to-cell basis: for approximately one-third of cells, P2Y1Rs are necessary for Ca2+ waves; for approximately one-fifth of cells, P2Y2Rs are necessary; and in the remaining cells, either receptor subtype is sufficient to support Ca2+ waves.

Apyrase suppresses Ca2+ waves and directs Ca2+ waves through P2Y1 receptors in spinal astrocytes

In spinal astrocytes, the propagation of Ca2+ waves depends on P2Y1Rs in ∼35% of cells because this is the proportion of cells in which Ca2+ waves are blocked by A3P5PS (Fam et al., 2000). To determine whether P2Y2Rs are required for Ca2+ wave propagation in spinal astrocytes, we investigated the effect of apyrase. We found that apyrase prevented propagation of Ca2+ waves to 11 of the 60 cells examined (Fig. 8a,c; n = 6 fields), implying that Ca2+ waves required activation of P2Y2Rs in the affected cells. The spread of Ca2+ waves in the presence of apyrase was reversibly suppressed by applying A3P5PS (100 μm; Fig. 8a,c), indicating that Ca2+ wave propagation during apyrase application is mediated by P2Y1Rs. The rate of propagation of the Ca2+ waves that persisted during apyrase was not different from the rate of wave propagation before applying apyrase (Fig. 8b). Thus, we conclude that for ∼20% of spinal astrocytes, Ca2+ wave propagation requires activation of P2Y2Rs. Also, during apyrase application, Ca2+ waves in spinal astrocytes are diverted away from P2Y2Rs and propagate through activation of P2Y1Rs.

Figure 8.

Figure 8.

Apyrase diverts Ca2+ waves through P2Y1Rs in spinal astrocyte cultures. Ca2+ waves were stimulated in spinal astrocytes in the absence and then in the presence of the nucleotidase apyrase. a, The color panels on the left show the prestimulation (pre) resting [Ca2+]i levels, whereas the panels in the middle show the maximum spread of the Ca2+ wave in control, apyrase (30 U/ml), apyrase and A3P5PS (10 μm) together, and after washout. The cell stimulated is labeled with a white arrow. The right panels show the time course of the changes of the 340/380 fura-2 emission ratios in each cell during the Ca2+ wave. b, Comparison of the rate of Ca2+ wave propagation in spinal astrocytes in pair-matched control Ca2+ waves and Ca2+ waves in apyrase. In this series of experiments, the mean rate of astrocyte Ca2+ wave propagation was 23.5 ± 1.9 μm/sec, whereas in apyrase, the rate of propagation of the Ca2+ wave was 27.2 ± 2.3 μm/sec (n = 49 cells in 6 fields). To determine whether in apyrase the Ca2+ waves were propagating by activation of P2Y1R, A3P5PS (10 μm) was included in the bathing medium along with apyrase. c, Mean percentage of cells in each field that participated in the Ca2+ wave under control conditions, in apyrase (n = 6 fields), and in both apyrase and A3P5PS (n = 2 fields).

Discussion

P2Y2 is the UTP-activated P2Y receptor in spinal astrocytes

That more than one subtype of P2YR is required for astrocyte Ca2+ waves was implied from previous findings that Ca2+ waves are blocked by broadly acting P2Y inhibitors but are only partially inhibited by the selective P2Y1R inhibitor A3P5PS. We therefore focused on identifying the P2YR mediating the A3P5PS-resistant ATP responses and Ca2+ waves in spinal astrocytes. By using RT-PCR, we demonstrated that in addition to P2Y1 (Fam et al., 2000), mRNA for P2Y2 is expressed in spinal dorsal horn cultures. Like the P2U receptor we had characterized previously, P2Y2Rs are activated by UTP, as well as by ATP, and are not affected by A3P5PS. P2Y2R function is blocked by suramin (Charlton et al., 1996), as are UTP-evoked Ca2+ responses in spinal astrocytes and the A3P5PS-resistant component of Ca2+ waves. Likewise, UTP-evoked Ca2+ responses and Ca2+ waves in spinal astrocytes are blocked by PPADS (discussed more fully below). The other P2YR subtype for which mRNA was detected in dorsal spinal cultures was P2Y4. Ca2+ responses mediated by recombinant rat P2Y4Rs were unaffected by suramin; thus, P2Y4R cannot account for the UTP-evoked response or A3P5PS-resistant component of Ca2+ waves in spinal astrocytes. The P2Y4 mRNA we detected may have been from nonastrocyte cell types found in the mixed spinal cord cultures used in the present study. Alternatively, P2Y4 mRNA might be present in spinal astrocytes but might not be translated, or translated protein may not reach the cell surface. Therefore, because the only functional UTP-activated P2YR we detected was P2Y2R, this fully accounts for the UTP-activated Ca2+ responses and the A3P5PS-resistant component of Ca2+ waves in spinal astrocytes.

Previously we found that UTP-activated Ca2+ responses in dorsal spinal astrocytes are competitively antagonized by PPADS (Ho et al., 1995). However, it has been reported that recombinant human P2Y2Rs are unaffected by PPADS (Charlton et al., 1996). On the basis of this pharmacological difference, we had suspected that the UTP-evoked response in spinal astrocytes might have been mediated via a P2YR that was not P2Y2. However, in the present study, we found that Ca2+ responses mediated by recombinant rat P2Y2Rs showed blockade by PPADS. Thus, there appears to be a rat versus human species difference in the sensitivity of the P2Y2R to PPADS. The primary sequence of the human P2Y2R is predicted to be 89% identical to that of the rat orthologue. The predicted ligand-interacting region of P2Y2R includes positively charged amino acids in the sixth and seventh transmembrane (TM) domains (Erb et al., 1995). Each of these TM domains has one conservative substitution: TM6, L248V; and TM7, I289V, which could potentially underlie the difference in sensitivity to PPADS. There are alternative regions that may account for this difference in the extracellular domains; thus, further studies are required to determine the molecular basis for the species difference in the sensitivity of P2Y2Rs to PPADS.

Apyrase selectively inhibits Ca2+ waves mediated by P2Y2 but not P2Y1 receptors

There is currently no available pharmacological antagonist that differentially inhibits P2Y2Rs but not P2Y1Rs. However, we found that the nucleotidase apyrase selectively suppresses activation of P2Y2Rs by degrading endogenous ATP but maintains activation of P2Y1Rs, presumably by producing ADP. In spinal astrocytes, bath applying apyrase prevented Ca2+ wave propagation to ∼20% of cells, implying that activation of P2Y2Rs is necessary for Ca2+ waves to spread to these cells. This finding also demonstrates that even with apyrase in the extracellular bathing solution, Ca2+ waves persist in ∼80% of spinal astrocytes by activation of P2Y1Rs. In previous studies, apyrase has been found to suppress Ca2+ waves between cortical astrocytes (Cotrina et al., 1998b; Guthrie et al., 1999) and retinal astrocytes (Newman, 2001) and Ca2+ waves from retinal astrocytes to Muller cells (Newman, 2001). On the other hand, apyrase was reported to have no effect on Ca2+ waves in striatal astrocytes (Venance et al., 1997). This lack of effect of apyrase was interpreted as strong evidence against involvement of ATP in propagation of striatal astrocyte Ca2+ waves. But an alternative explanation is that Ca2+ waves in these astrocytes are mediated by ATP: the lack of effect of apyrase is consistent with waves mediated by P2Y1Rs or with waves mediated by P2Y2Rs in control conditions and by P2Y1Rs in the presence of apyrase. In the retina, apyrase has a much greater effect on astrocyte-Muller cell Ca2+ waves than on astrocyte-astrocyte Ca2+ waves (Newman, 2001), which may indicate that the relative contribution of P2Y2Rs versus P2Y1Rs is greater for astrocyte-Muller cell Ca2+ waves than for astrocyte-astrocyte waves. Generally, our findings with apyrase under conditions in which we differentially expressed P2Y1Rs, P2Y2Rs, or both demonstrate that the effect of this nucleotidase on Ca2+ wave propagation in a given system will be critically dependent on the subtype of P2YRs expressed.

Distinctive characteristics of Ca2+ waves mediated by P2Y2Rs versus P2Y1Rs

A striking finding of the present study is that Ca2+ waves mediated by P2Y2Rs propagate much more rapidly than do those mediated by P2Y1Rs, a difference accounted for by more rapid ATP-evoked Ca2+ responses of P2Y2Rs than of P2Y1Rs. The slower speed at which Ca2+ responses were produced by P2Y1Rs was not an intrinsic property of signaling via this receptor subtype because Ca2+ responses of P2Y1Rs evoked by ADP were as rapid as the ATP-stimulated responses of P2Y2Rs. As predicted from this difference in signaling, we found that Ca2+ waves mediated via P2Y1Rs were accelerated by facilitating the extracellular conversion of ATP to ADP by apyrase, an effect that would not have been expected from previous studies.

For Ca2+ waves to be mediated by ATP, the wave of increased [Ca2+]i needs to be preceded by a rise in extracellular ATP, and this has been demonstrated in retina (Newman, 2001) and in hippocampal cultures (Wang et al., 2000). The time required for released ATP to reach sufficient concentrations to stimulate P2YRs is one main factor that determines the rate of spread of Ca2+ waves. The other principal factor determining the speed at which Ca2+ waves spread is the rate at which the stimulated P2YRs produce a rise in [Ca2+]i. As can be most readily seen in our studies in which we mixed cells expressing either P2Y1Rs or P2Y2Rs (e.g., Fig. 4), the relative contribution of these two factors may dramatically affect the speed of Ca2+ wave propagation. Ca2+ waves mediated by P2Y2Rs will tend toward the maximum rate allowed by the rise in extracellular ATP. On the other hand, waves mediated by P2Y1Rs will be markedly slower than the rise in extracellular ATP, owing to the additional signaling time required for activation of this receptor by ATP.

In the literature, a wide range of rates of propagation of astrocyte Ca2+ waves has been reported. These rates appear to cluster into a slower range of 5-10 μm/sec (Dani et al., 1992; Harris-White et al., 1998; John et al., 1999) and a faster range of 13-25 μm/sec (Nedergaard, 1994; Hassinger et al., 1996; Newman and Zahs, 1997; Venance et al., 1997; Schipke et al., 2002; present study). A potential explanation for the divergence in the rates of Ca2+ wave propagation is afforded by our present study: in preparations with the slower rates of propagation, it is possible that P2Y1Rs may have a predominant role in mediating Ca2+ waves, whereas in preparations with the more rapid rates, the P2Y2Rs might be dominant. Because signaling by G-protein-coupled receptors, such as P2YRs, is highly regulated in cells (Ferguson, 2001; Pierce et al., 2002), it is possible that the signal transduction rate of P2Y1Rs and P2Y2Rs might itself be subject to modification by a variety of intracellular processes. This may further contribute to divergence in rates and, in addition, may allow for context-dependent modulation of the rate of Ca2+ wave propagation.

Gliotransmission via ATP and two subtypes of P2Y receptors

Propagation of Ca2+ waves by a diffusible chemical messenger is the principal form of astrocyte-astrocyte communication, increasingly referred to as gliotransmission. The preponderance of evidence indicates that the diffusible chemical messenger, or gliotransmitter, mediating Ca2+ waves is ATP. We have shown in the present study that in spinal astrocytes, two nucleotide receptors, P2Y1 and P2Y2, serve as gliotransmitter receptors detecting and responding to released ATP. These receptors are differentially activated by the gliotransmitter: P2Y2Rs mediate a fast response to extracellular ATP, whereas P2Y1Rs mediate a relatively slower response to ATP. Although either receptor subtype is sufficient to support Ca2+ waves, the rate and extent of the spread of the waves are governed by the subtype of gliotransmitter receptor engaged. Because ATP-mediated Ca2+ waves are observed in astrocytes in various regions of the CNS, we suggest that the concept of one gliotransmitter, ATP, and two gliotransmitter receptors, P2Y1 and P2Y2, may be a general principle of gliotransmission throughout the CNS. It is possible that there are regional or developmental differences in the relative contributions of these two receptor subtypes to Ca2+ waves. Additionally, within a given region, the expression or function of the receptors or both may be subject to regulation that may alter the dynamic properties of the spread of Ca2+ waves.

Footnotes

This work was supported by grants from the Canadian Institutes of Health Research (M.W.S.) and the Ontario Neurotrauma Foundation (C.J.G.). C.J.G. is a clinician-scientist trainee at the Hospital for Sick Children, and M.W.S. is a Canadian Institutes of Health Research investigator. We thank J. L. Hicks and David Wong for preparing and maintaining dorsal horn cultures. We also thank Dr. G. I. Bell for the rat P2Y1 cDNA and Dr. Z.-P. Chen for the rat P2Y2 cDNA.

Correspondence should be addressed to Michael W. Salter, Programme in Brain and Behaviour, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. E-mail: mike.salter@utoronto.ca.

Copyright © 2003 Society for Neuroscience 0270-6474/03/236728-12$15.00/0

References

  1. Araque A, Martin ED, Perea G, Arellano JI, Buno W ( 2002) Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices. J Neurosci 22: 2443-2450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bezzi P, Volterra A ( 2001) A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 11: 387-394. [DOI] [PubMed] [Google Scholar]
  3. Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G ( 1998) Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br J Pharmacol 124: 428-430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Charles AC, Merrill JE, Dirksen ER, Sanderson MJ ( 1991) Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron 6: 983-992. [DOI] [PubMed] [Google Scholar]
  5. Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR ( 1996) PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol 118: 704-710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ ( 1990) Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 247: 470-473. [DOI] [PubMed] [Google Scholar]
  7. Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M ( 1998a) Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 95: 15735-15740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cotrina ML, Lin JH, Nedergaard M ( 1998b) Cytoskeletal assembly and ATP release regulate astrocytic calcium signaling. J Neurosci 18: 8794-8804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crack BE, Pollard CE, Beukers MW, Roberts SM, Hunt SF, Ingall AH, McKechnie KC, Ijzerman AP, Leff P ( 1995) Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 114: 475-481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dani JW, Chernjavsky A, Smith SJ ( 1992) Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron 8: 429-440. [DOI] [PubMed] [Google Scholar]
  11. Erb L, Garrad R, Wang Y, Quinn T, Turner JT, Weisman GA ( 1995) Site-directed mutagenesis of P2U purinoceptors: positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem 270: 4185-4188. [DOI] [PubMed] [Google Scholar]
  12. Fam SR, Gallagher CJ, Salter MW ( 2000) P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes. J Neurosci 20: 2800-2808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferguson SS ( 2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24. [PubMed] [Google Scholar]
  14. Guan X, Cravatt BF, Ehring GR, Hall JE, Boger DL, Lerner RA, Gilula NB ( 1997) The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J Cell Biol 139: 1785-1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Guthrie PB, Knappenberger J, Segal M, Bennett MV, Charles AC, Kater SB ( 1999) ATP released from astrocytes mediates glial calcium waves. J Neurosci 19: 520-528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harris-White ME, Zanotti SA, Frautschy SA, Charles AC ( 1998) Spiral intercellular calcium waves in hippocampal slice cultures. J Neurophysiol 79: 1045-1052. [DOI] [PubMed] [Google Scholar]
  17. Hassinger TD, Guthrie PB, Atkinson PB, Bennett MV, Kater SB ( 1996) An extracellular signaling component in propagation of astrocytic calcium waves. Proc Natl Acad Sci USA 93: 13268-13273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ho C, Hicks J, Salter MW ( 1995) A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat. Br J Pharmacol 116: 2909-2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, Spray DC, Brosnan CF ( 1999) IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA 96: 11613-11618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. King BF, Townsend-Nicholson A, Burnstock G ( 1998) Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol Sci 19: 506-514. [DOI] [PubMed] [Google Scholar]
  21. Neary JT, van Breemen C, Forster E, Norenberg LO, Norenberg MD ( 1988) ATP stimulates calcium influx in primary astrocyte cultures. Biochem Biophys Res Commun 157: 1410-1416. [DOI] [PubMed] [Google Scholar]
  22. Nedergaard M ( 1994) Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263: 1768-1771. [DOI] [PubMed] [Google Scholar]
  23. Newman EA ( 2001) Propagation of intercellular calcium waves in retinal astrocytes and Muller cells. J Neurosci 21: 2215-2223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Newman EA, Zahs KR ( 1997) Calcium waves in retinal glial cells. Science 275: 844-847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Newman EA, Zahs KR ( 1998) Modulation of neuronal activity by glial cells in the retina. J Neurosci 18: 4022-4028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. North RA, Barnard EA ( 1997) Nucleotide receptors. Curr Opin Neurobiol 7: 346-357. [DOI] [PubMed] [Google Scholar]
  27. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L, Weisman GA, Boucher RC, Turner JT ( 1994) Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91: 3275-3279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Peterson ER, Crain SM ( 1982) Nerve growth factor attenuates neurotoxic effects of taxol on spinal cord-ganglion explants from fetal mice. Science 217: 377-379. [DOI] [PubMed] [Google Scholar]
  29. Pierce KL, Premont RT, Lefkowitz RJ ( 2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3: 639-650. [DOI] [PubMed] [Google Scholar]
  30. Salter MW, Hicks JL ( 1994) ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord. J Neurosci 14: 1563-1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sambrook J, Russell DW ( 2001) Molecular cloning, Ed 3. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
  32. Schipke CG, Boucsein C, Ohlemeyer C, Kirchhoff F, Kettenmann H ( 2002) Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J 16: 255-257. [DOI] [PubMed] [Google Scholar]
  33. Varadaraj K, Skinner DM ( 1994) Denaturants or cosolvents improve the specificity of PCR amplification of a G + C-rich DNA using genetically engineered DNA polymerases. Gene 140: 1-5. [DOI] [PubMed] [Google Scholar]
  34. Venance L, Stella N, Glowinski J, Giaume C ( 1997) Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J Neurosci 17: 1981-1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vernadakis A ( 1996) Glia-neuron intercommunications and synaptic plasticity. Prog Neurobiol 49: 185-214. [DOI] [PubMed] [Google Scholar]
  36. Wang Z, Haydon PG, Yeung ES ( 2000) Direct observation of calcium-independent intercellular ATP signaling in astrocytes. Anal Chem 72: 2001-2007. [DOI] [PubMed] [Google Scholar]
  37. Westfall TD, Kennedy C, Sneddon P ( 1997) The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder. Eur J Pharmacol 329: 169-173. [PubMed] [Google Scholar]
  38. Zimmermann H ( 2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Neuroscience are provided here courtesy of Society for Neuroscience

RESOURCES